JXPCB(688655)2024-04-26 11:41Financial Performance - The company's operating revenue for Q1 2024 was ¥101,736,786.98, representing a decrease of 4.49% compared to the same period last year[3]. - The net profit attributable to shareholders was -¥1,259,405.20, a decline of 120.15% year-over-year[3]. - The net profit excluding non-recurring gains and losses was -¥3,169,828.38, a significant decline of 246.32% year-over-year[3]. - Total revenue for Q1 2024 was CNY 101.74 million, a decrease of 4.8% from CNY 106.51 million in Q1 2023[18]. - Net profit for Q1 2024 was a loss of CNY 1.26 million, compared to a profit of CNY 6.25 million in Q1 2023, marking a significant decline[19]. - Operating profit for Q1 2024 was reported at a loss of CNY 1.28 million, down from a profit of CNY 6.67 million in Q1 2023[19]. - In Q1 2024, the company's net profit was CNY 4,080,311.38, a decrease of 26.8% compared to CNY 5,577,433.90 in Q1 2023[30]. - The total profit for Q1 2024 was CNY 4,149,352.60, down 32.5% from CNY 6,151,948.60 in Q1 2023[30]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 69.1%, amounting to ¥5,316,992.52[3]. - Cash inflow from operating activities was CNY 111.80 million, down 35% from CNY 171.89 million in Q1 2023[22]. - The cash flow from sales of goods and services decreased to CNY 104.53 million, down 37.2% from CNY 166.53 million in Q1 2023[22]. - The company reported a cash flow increase of CNY 46,853,990.65 in Q1 2024, compared to an increase of CNY 20,492,989.91 in Q1 2023[33]. - The company reported a net cash increase of ¥69,211,422.23 for the quarter, compared to ¥25,738,855.00 in the same period last year, an increase of 169.0%[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,088,102,644.16, reflecting a growth of 4.93% from the end of the previous year[4]. - The total assets as of March 31, 2024, amounted to ¥841,376,343.65, an increase from ¥742,279,012.49 at the end of 2023[27]. - Total liabilities rose to CNY 395.64 million, compared to CNY 344.70 million in the previous year, reflecting a 14.8% increase[16]. - The total liabilities increased to ¥229,870,094.04 from ¥136,320,037.35, reflecting a rise of 68.7%[27]. - The company reported a total of RMB 420,852,229.61 in current assets, down from RMB 440,617,087.85, reflecting a decrease of about 4.5%[14]. Research and Development - Research and development expenses totaled ¥8,322,407.48, which is an increase of 14.68% and represents 8.18% of operating revenue, up by 1.37 percentage points[3]. - Research and development expenses increased to CNY 8.32 million, up 14.7% from CNY 7.26 million in Q1 2023[18]. - Research and development expenses for Q1 2024 were ¥4,039,439.95, up from ¥3,469,218.30 in Q1 2023, representing an increase of 16.4%[29]. Market and Strategic Initiatives - The company plans to enhance market expansion efforts and accelerate capacity ramp-up to mitigate adverse impacts on production and operations[7]. - The company is exploring market expansion opportunities, particularly in the domestic market, to enhance its competitive position[11]. - The company has ongoing investments in new technologies and products, although specific details were not disclosed in the report[11]. Shareholder and Ownership Structure - There were no significant changes in the shareholding structure among the top shareholders during the reporting period[11]. - The company has not reported any new mergers or acquisitions in the current quarter[11].